ALEXANDER GOLDBERG: Open Payments
NPI 1952371734 · MANALAPAN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,719 in 83 payments from 19 companies in 2025. Trend: 2023 $1,490 · 2024 $1,700 · 2025 $1,719
Food & beverage: $1,670Education: $48
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $417 |
| AstraZeneca Pharmaceuticals LP | 9 | $259 |
| Janssen Biotech, Inc. | 11 | $192 |
| Axsome Therapeutics, Inc. | 1 | $124 |
| PFIZER INC. | 6 | $110 |
| Exact Sciences Corporation | 3 | $100 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $83 |
| Novo Nordisk Inc | 4 | $71 |
| Lilly USA, LLC | 4 | $65 |
| Antares Pharma, Inc. | 3 | $54 |
Products named: QULIPTA, TREMFYA, BREZTRI, Symbravo, Cologuard Collection Kit, NURTEC ODT, LINZESS, Kerendia.
Industry payments across NJ — which companies pay providers there.
